At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Aug 12, 2026 at 17:04 ET
Insmed's COO and CMO sold a combined $33.1M in stock immediately following a blockbuster Q2 earnings beat (revenue $425.5M vs. $393.4M consensus) and raised guidance. The COO's $32M sale is the dominant event, executed after exercising options at much lower strike prices. While the earnings were strongly bullish, the insider sales are likely liquidity-driven post-vesting and are trivial relative to the $29B market cap (0.11%), making this a neutral cluster signal that does not offset the positive fundamental momentum.
- COO Roger Adsett sold 239,850 shares for $31.96M on 2026-08-10 after exercising options at $0-$30.46.
- CMO Martina Flammer sold 27,173 shares total for $3.49M on 2026-08-06 after exercising options at $0-$25.83.
- Total insider sales of $33.09M represent just 0.11% of INSM's $29B market cap.
- Sales occurred 4-5 days after Q2 2026 earnings beat: revenue $425.5M vs. $393.4M consensus, raised FY2026 BRINSUPRI guidance to $1.25B-$1.4B.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access